Chemist.net Cookie Policy : We use cookies to enhance your user experience. To find out more please view our cookie policy
Docusate Sodium Paediatric 12.5mg/5ml Solution 300ml
Docusate Sodium Paediatric 12.5mg/5ml Solution is used to prevent and treat constipation in infants and children aged 6 months to 12 years.
Browse our full range of:
Description
Docusate Sodium Paediatric 12.5mg/5ml Solution
Docusate Sodium Paediatric 12.5mg/5ml Solution is used to prevent and treat constipation in infants and children aged 6 months to 12 years, and may also be used before a stomach x-ray. The active ingredient, docusate sodium, belongs to a group of medicines called 'laxatives'.
Directions
Always take this medicine exactly as described in the leaflet or as the patient's doctor or pharmacist have told you. Check with the patient's doctor or pharmacist if you are not sure.
Constipation
- The recommended dose for infants aged over 6 months is one 5ml spoonful three times a day.
- The recommended dose for children aged 2-12 years is one to two 5ml spoonfuls three times a day.
Dilute the medicine in a glass of flavoured drink such as fruit juice or milk and give to the patient to drink within 30 minutes of preparation.
Reduce the dose as the condition improves.
Use before stomach X-ray
When taken before a stomach X-ray the dose is six 5ml spoonfuls, as a single dose.
Docusate sodium may cause an unpleasant aftertaste or burning sensation. This may be minimised by drinking plenty after taking the solution.
Ingredients
- Active Ingredient: Docusate sodium (12.5mg/5ml).
- Other Ingredients: Dependent on brand.
Cautions
- Docusate Sodium Paediatric 12.5mg/5ml Solution contains methyl p-hydroxybenzoate 5mg and propyl p-hydroxybenzoate 2.5mg in each dose (5ml). May cause allergic reactions (possibly delayed).
- Docusate Sodium Paediatric 12.5mg/5ml Solution contains 1290mg of sorbitol in each dose (5ml). Sorbitol is a source of fructose. If the patient's doctor has told you that the patient has an intolerance to some sugars or if the patient has been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which a person cannot break down fructose, talk to a doctor before the patient takes this medicine. Sorbitol may cause gastrointestinal discomfort and mild laxative effect.
- Docusate Sodium Paediatric 12.5mg/5ml Solution 15mg of aspartame per dose (5ml). Aspartame is a source of phenylalanine. It may be harmful if you have phenylketonuria (PKU), a rare genetic disorder in which phenylalanine builds up because the body cannot remove it properly.
- Docusate Sodium Paediatric 12.5mg/5ml Solution contains less than 1 mmol sodium (23 mg) per 5m' dose, that is to say essentially 'sodium-free'.
- Talk to the patient's doctor or pharmacist before the patient starts taking Docusate Sodium Paediatric 12.5mg/5ml Solution.
- Docusate Sodium Paediatric 12.5mg/5ml Solution should not be given to infants under the age of 6 months.
- Prolonged use can cause the gut to become lazy and not work properly.
- Tell the patient's doctor or pharmacist if the patient is taking, have recently taken or might take any other medicines. Docusate Sodium Paediatric 12.5mg/5ml Solution should not be taken if the patient is already taking mineral oil. Patients already taking other laxatives called anthraquinone laxatives such as senna, will need to take reduced doses as Docusate Sodium Paediatric 12.5mg/5ml Solution increases their effects.
Do not give Docusate Sodium Paediatric 12.5mg/5ml Solution:
- If the patient is allergic to docusate sodium or any of the other ingredients of this medicine.
- If the patient is suffering from stomach pains or an obstruction in the gut.
- If the patient is feeling sick or has been sick in the last 24 hours.